Intrinsiqq
Apimeds Pharmaceuticals Inc. logo

Apimeds Pharmaceuticals Inc. Insider Trading

APUS

Compare
Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in May 2025.

Net open-market
$0
0 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
0 / 0
executives and directors
Last open-market buy
May 2025
May 14, 2025

Get an email when APUS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • May 13, 2025 – May 14, 2025
    Christopher Kim
    Chairman and CMO · bought 27,500 at avg $1.83
    50K
    New position
  • May 12, 2025
    Jakap Koo
    Director · bought 28,500 at $1.99
    57K
    4.6% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch APUS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with APUS

CompareIntrinsic value
PMHSPolomar Health Services Inc.
$0.15+45.00%30
TCRTAlaunos Therapeutics Inc.
$1.66+4.40%10
PULMPulmatrix Inc.
$1.28-10.21%40
OTLCOncotelic Therapeutics Inc.
$0.01+22.00%10
GTBPGT Biopharma, Inc.
$2.96-6.92%20
DAREDare Bioscience Inc.
$0.41-9.96%10
PTNPalatin Technologies, Inc.
$4.58-7.10%10
ONCOOnconetix Inc.
$2.89-8.54%50

Spot a number that looks wrong? Check it in APUS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing APUS

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.